Molecular prognostication in bladder cancer—a current perspective
Authors:
- M.L QuekMQM.L Quek
- D.I QuinnDQD.I Quinn
- S DaneshmandSDS Daneshmand
- J.P SteinJSJ.P Stein
- 1 July 2003
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 39 (11) , 1501-1510
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- OVER EXPRESSION OF CD44V8-10 IN URINARY EXFOLIATED CELLS AS AN INDEPENDENT PROGNOSTIC PREDICTOR IN PATIENTS WITH UROTHELIAL CANCERJournal of Urology, 2002
- Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder CarcinomasThe American Journal of Pathology, 2000
- The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cellsCarcinogenesis, 2000
- The Hallmarks of CancerCell, 2000
- Options available — from start to finish — for obtaining expression data by microarrayNature Genetics, 1999
- Cancer Cell CyclesScience, 1996
- Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of PaclitaxelJNCI: Journal of the National Cancer Institute, 1996
- C-ERBB-2 in Bladder Cancer: Molecular Biology, Correlation with Epidermal Growth Factor Receptors and Prognostic ValueJournal of Urology, 1996
- Purification and Characterization of the XPF-ERCC1 Complex of Human DNA Repair Excision NucleaseJournal of Biological Chemistry, 1995
- Myc—Max—Mad: a transcription factor network controlling cell cycle progression, differentiation and deathCurrent Opinion in Genetics & Development, 1994